Powered by

Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting

Nov 19, 2020 - GlobeNewswire

WAYNE, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the results of four studies that were accepted at the ICS 2020 Annual Meeting – Online reinforcing the safety and efficacy of the UroLift ® System for the treatment of benign prostatic hyperplasia (BPH).

“BPH commonly causes bothersome urinary symptoms that can affect quality of life. With over 40% of men over the age 50 living with BPH, 1 the robust data presented at ICS highlight the ...